Mohammadreza Ghaffarlou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohammadreza Ghaffarlou has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alkin Ozgen
Hacettepe University
2 shared publications - Busra Kilic
Department of Biology, Faculty of Science, Molecular Biology Section, Hacettepe University, 06800 Ankara, Türkiye
2 shared publications - Halil Murat Aydin
Hacettepe University
2 shared publications - Ali Ramazani
The Organic Chemistry Research Laboratory (OCRL), Department of Chemistry, Faculty of Science, University of Zanjan, Zanjan, 45371-38791, Iran.
1 shared publication - Cagatay Karaaslan
Department of Biology Faculty of Science Molecular Biology Section Hacettepe University Ankara Turkey
1 shared publication - Faezeh Mozafari
Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA
1 shared publication
Latest Publications
- 11 September 2025
- Published by Wiley in Macromolecular Bioscience
- Vol. 25 (12) , e00298
Development of Injectable and Self‐Healing Gelatin/Dextran/Tannic Acid Composite Hydrogels Incorporating PCL/β‐Tricalcium Phosphate Microspheres for Bone Tissue Regeneration
The current study introduces a novel hybrid system of polycaprolactone‐nano beta‐tricalcium phosphate microspheres (PCL‐β‐TCP Ms) combined with a hydrogel, which acts as a bone scaffold to accelerate osteogenic capabilities. This innovative system comprises a gelatin (Gel), oxidized dextran (Odex), and tannic acid (TA) hydrogel that integrates PCL‐β‐TCP microspheres. The Schiff base reaction between Gel and Odex, and the hydrogen bonding interaction of tannic acid and polymers, developed the hydrogel substrate. The process of fabricating the β‐TCP‐encapsulated PCL microspheres involved using the emulsion solvent evaporation technique, a method that allows for the encapsulation of bioactive substances within the microspheres. The findings revealed that incorporating microsphere‐encapsulated β‐TCP into the hydrogels notably enhanced their rheological properties, contributing to improved flow behavior and structural integrity. Additionally, the scanning electron microscopy (SEM) images illustrate that the addition of tannic acid leads to the development of a prominent fibrous structure within the hydrogels. This structural enhancement indicates that the presence of tannic acid plays a crucial role in modifying the hydrogel's composition at a microscopic level. The study investigated the interactions between biological cells and hybrid hydrogels in an in vitro setting. The viability and cytotoxicity testing demonstrated no adverse effects of the hybrid system (Gel/Odex/TA/PCL‐β‐TCP) and significantly improved preosteoblast cell (MC3T3‐E1) viability. Moreover, the addition of these microspheres indicated a favorable environment for cell growth and development. Furthermore, Gel/Odex/TA/6%PCL‐β‐TCP Ms and Gel/Odex/TA/4%PCL‐β‐TCP Ms hydrogels exhibited a significant increase in calcium deposition and alkaline phosphatase (ALP) activity, respectively. These results reinforce that this multifunctional composite hydrogel may serve as a promising scaffold for bone tissue regeneration.
- 11 September 2025
- Published by Wiley in Macromolecular Bioscience
- Vol. 25 (12) , e00298
Development of Injectable and Self‐Healing Gelatin/Dextran/Tannic Acid Composite Hydrogels Incorporating PCL/β‐Tricalcium Phosphate Microspheres for Bone Tissue Regeneration
The current study introduces a novel hybrid system of polycaprolactone‐nano beta‐tricalcium phosphate microspheres (PCL‐β‐TCP Ms) combined with a hydrogel, which acts as a bone scaffold to accelerate osteogenic capabilities. This innovative system comprises a gelatin (Gel), oxidized dextran (Odex), and tannic acid (TA) hydrogel that integrates PCL‐β‐TCP microspheres. The Schiff base reaction between Gel and Odex, and the hydrogen bonding interaction of tannic acid and polymers, developed the hydrogel substrate. The process of fabricating the β‐TCP‐encapsulated PCL microspheres involved using the emulsion solvent evaporation technique, a method that allows for the encapsulation of bioactive substances within the microspheres. The findings revealed that incorporating microsphere‐encapsulated β‐TCP into the hydrogels notably enhanced their rheological properties, contributing to improved flow behavior and structural integrity. Additionally, the scanning electron microscopy (SEM) images illustrate that the addition of tannic acid leads to the development of a prominent fibrous structure within the hydrogels. This structural enhancement indicates that the presence of tannic acid plays a crucial role in modifying the hydrogel's composition at a microscopic level. The study investigated the interactions between biological cells and hybrid hydrogels in an in vitro setting. The viability and cytotoxicity testing demonstrated no adverse effects of the hybrid system (Gel/Odex/TA/PCL‐β‐TCP) and significantly improved preosteoblast cell (MC3T3‐E1) viability. Moreover, the addition of these microspheres indicated a favorable environment for cell growth and development. Furthermore, Gel/Odex/TA/6%PCL‐β‐TCP Ms and Gel/Odex/TA/4%PCL‐β‐TCP Ms hydrogels exhibited a significant increase in calcium deposition and alkaline phosphatase (ALP) activity, respectively. These results reinforce that this multifunctional composite hydrogel may serve as a promising scaffold for bone tissue regeneration.
- Open Access
- 6 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (6) , 4014-4028
Injectable carboxymethyl chitosan/oxidized dextran hydrogels containing zoledronic acid modified strontium hydroxyapatite nanoparticles
Nanocomposite hydrogels have potential in bone regeneration due to the inorganic and polymeric material content. In this study, new types of nanocomposite hydrogels composed of zoledronic acid/strontium hydroxyapatite nanoparticles and carboxymethyl chitosan/oxidized dextran (CMC/OD) hydrogels were reported. Pure hydroxyapatite, 5%, 10% and 15% (w/w) strontium-substituted strontium hydroxyapatite nanoparticles were produced and then modified with zoledronic acid at ratios of 5% to 7.5% (w/w). These modified structures were then incorporated into CMC/OD hydrogels. Zoledronic acid modified strontium hydroxyapatite nanoparticles were characterized using Scanning Electron Microscopy (SEM), Energy Dispersive X-ray Spectroscopy (EDS) and X-ray Diffraction (XRD). CMC/OD structures were investigated using Fourier Transform Infrared Analysis (FTIR), Scanning Electron Microscopy (SEM). The physical properties of the hydrogels were determined via degradation behavior and rheological measurements. Cell–material interactions were investigated in vitro. The results showed that the incorporation of hydroxyapatite nanoparticles into CMC would significantly improve the rheological properties. The addition of strontium to hydroxyapatite nanoparticles significantly enhanced cell proliferation. In addition, a significant increase in alkaline phosphatase (ALP) and calcium deposition was observed with the addition of zoledronic acid. In conclusion, the nanocomposite hydrogels of CMC/OD containing zoledronic acid modified strontium hydroxyapatite demonstrate potential for orthopedic and craniofacial applications due to their superior properties, including the ability to be easily injected into targeted areas, potent antibacterial activity that helps prevent infections and remarkable self-healing capabilities that promote tissue regeneration and repair.
- 6 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (6) , 4014-4028
Open AccessInjectable carboxymethyl chitosan/oxidized dextran hydrogels containing zoledronic acid modified strontium hydroxyapatite nanoparticles
Nanocomposite hydrogels have potential in bone regeneration due to the inorganic and polymeric material content. In this study, new types of nanocomposite hydrogels composed of zoledronic acid/strontium hydroxyapatite nanoparticles and carboxymethyl chitosan/oxidized dextran (CMC/OD) hydrogels were reported. Pure hydroxyapatite, 5%, 10% and 15% (w/w) strontium-substituted strontium hydroxyapatite nanoparticles were produced and then modified with zoledronic acid at ratios of 5% to 7.5% (w/w). These modified structures were then incorporated into CMC/OD hydrogels. Zoledronic acid modified strontium hydroxyapatite nanoparticles were characterized using Scanning Electron Microscopy (SEM), Energy Dispersive X-ray Spectroscopy (EDS) and X-ray Diffraction (XRD). CMC/OD structures were investigated using Fourier Transform Infrared Analysis (FTIR), Scanning Electron Microscopy (SEM). The physical properties of the hydrogels were determined via degradation behavior and rheological measurements. Cell–material interactions were investigated in vitro. The results showed that the incorporation of hydroxyapatite nanoparticles into CMC would significantly improve the rheological properties. The addition of strontium to hydroxyapatite nanoparticles significantly enhanced cell proliferation. In addition, a significant increase in alkaline phosphatase (ALP) and calcium deposition was observed with the addition of zoledronic acid. In conclusion, the nanocomposite hydrogels of CMC/OD containing zoledronic acid modified strontium hydroxyapatite demonstrate potential for orthopedic and craniofacial applications due to their superior properties, including the ability to be easily injected into targeted areas, potent antibacterial activity that helps prevent infections and remarkable self-healing capabilities that promote tissue regeneration and repair.
- 5 September 2022
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 36 (11)
Preparation and evaluation of bismuth sulfide and magnetite‐based theranostic nanohybrid as drug carrier and dual MRI/CT contrast agent
Due to the increased incidence and population growth that has been leading to growing number of cases worldwide, early diagnosis and treatment of cancer is crucial. Low density cancer tissue cannot be diagnosed before progressing toward a metastatic stage. Thus, theranostic systems play a significant role in assisting timely diagnosis and treatment. The combination of magnetic resonance imaging (MRI) and computed tomography (CT) contrast agents in a single probe is of high importance and necessity, where individual strengths of each approach can be merged while shortcomings of each modality could be compensated. With this motivation, we have developed and synthesized Bi2S3@BSA‐Fe3O4 nanoparticles as a dual MRI/CT contrast agent and carrier of curcumin (CUR) as natural anticancer drug. The nanoparticles shortened both the longitudinal (T1) and transverse (T2), MRI relaxation times, with a more distinct effect on producing negative contrast (T2) images with a relaxivity (r2) of 54.73 mM−1 s−1. The magnetite/bismuth hybrid nanoparticle also was capable of increasing CT image contrast. Further, in vitro cytotoxicity assay showed high biocompatibility of the synthesized nanoparticles. Furthermore, in vitro cytotoxicity assay on cancer cells showed high anticancer activity of the synthesized nanoparticles.
- 5 September 2022
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 36 (11)
Preparation and evaluation of bismuth sulfide and magnetite‐based theranostic nanohybrid as drug carrier and dual MRI/CT contrast agent
Due to the increased incidence and population growth that has been leading to growing number of cases worldwide, early diagnosis and treatment of cancer is crucial. Low density cancer tissue cannot be diagnosed before progressing toward a metastatic stage. Thus, theranostic systems play a significant role in assisting timely diagnosis and treatment. The combination of magnetic resonance imaging (MRI) and computed tomography (CT) contrast agents in a single probe is of high importance and necessity, where individual strengths of each approach can be merged while shortcomings of each modality could be compensated. With this motivation, we have developed and synthesized Bi2S3@BSA‐Fe3O4 nanoparticles as a dual MRI/CT contrast agent and carrier of curcumin (CUR) as natural anticancer drug. The nanoparticles shortened both the longitudinal (T1) and transverse (T2), MRI relaxation times, with a more distinct effect on producing negative contrast (T2) images with a relaxivity (r2) of 54.73 mM−1 s−1. The magnetite/bismuth hybrid nanoparticle also was capable of increasing CT image contrast. Further, in vitro cytotoxicity assay showed high biocompatibility of the synthesized nanoparticles. Furthermore, in vitro cytotoxicity assay on cancer cells showed high anticancer activity of the synthesized nanoparticles.